Benchmark cuts Marzetti stock price target on weak retail volumes By Investing.com

Marzetti’s fiscal Q3 2026 results missed estimates across the board, with revenue of $453 million versus $464 million consensus, adjusted EPS of $1.43 versus $1.57 expected, and adjusted EBITDA of $66 million coming in about $5 million light. SG&A rose 9.5% year over year to $61 million, driven by acquisition and growth investments, while softer retail volumes pressured sales. Benchmark cut its price target to $160 from $200 but kept a Buy rating, citing a more mature growth profile yet constructive medium-term outlook.

Analysis

MZTI’s miss is less about one quarter and more about the market re-pricing a slower terminal growth rate. When a branded food asset gets reset from a growth multiple to a mature multiple, the downside is usually not the print itself but the reset in what investors are willing to pay for incremental acquisitions and internal reinvestment. The acquisition-related SG&A step-up matters because it implies the company is spending to defend optionality, yet the near-term volume softness suggests those dollars are not converting into visible demand elasticity.

The second-order risk is that retailer and consumer weakness can compress both sides of the P&L at once: lower turns reduce bargaining leverage with channels, while fixed overhead and IT/personnel investments keep op-ex sticky. That creates a multi-quarter margin pressure story, not a one-off earnings miss. If management continues to lean on M&A to offset organic slowing, the market may start valuing deal execution as a source of dilution rather than growth, especially if integration synergies lag.

Contrarian view: the selloff may already be pricing in a recessionary outcome that is too severe for a defensively positioned consumer staple. Near 52-week lows, any stabilization in retail volumes or evidence that Bachan’s is accretive could trigger a sharp multiple rebound, because short-duration disappointment in staples often mean-reverts faster than investors expect. The key is whether Q4/Q1 commentary confirms demand stabilization; absent that, the stock can stay cheap for months, but a single clean guide-up could force a fast repricing.

Key Decisions for Investors

• Avoid adding long MZTI until management proves retail volume stabilization; the next 1-2 quarters are the catalyst window, and the risk/reward is still skewed to another 5-10% multiple compression if guidance remains soft.
• For event-driven accounts, consider a tactical short MZTI into any post-earnings bounce, with a 4-8 week horizon and tight risk management above the pre-gap resistance; the thesis is continued de-rating toward a lower forward EBITDA multiple.
• Pair trade idea: long a higher-quality defensive staple with cleaner organic growth versus short MZTI to isolate company-specific execution risk and reduce market beta; this works best over the next 1-3 months if food demand remains uneven.
• If you want convexity on a rebound, use call spreads on MZTI dated 3-6 months out rather than outright stock; the setup is a sharp upside reaction if the market decides the miss was transient, but theta decay is favorable if the stock stagnates.
• Monitor retailer scan data and management commentary on Bachan’s integration over the next two earnings cycles; a visible re-acceleration in volumes would be the highest-probability trigger to cover shorts and rotate back long.